Pyridostigmine
Back to searchMolecule Structure
Scientific Name
Pyridostigmine
Description of the Drug
Pyridostigmine is a cholinesterase inhibitor used for symptomatic treatment of myasthenia gravis and congenital myasthenic syndromes and to reverse neuromuscular blockade by nondepolarizing muscle relaxants.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00545
http://www.drugbank.ca/drugs/DB00545
Brand Name(s)
Not Available
Company Owner(s)
Elysium Pharmaceuticals Ltd, Amneal Pharmaceuticals Llc, Impax Laboratories Inc, Eywa Pharma Inc, Sandoz Inc, Alvogen Inc, Ani Pharmaceuticals Inc, Milla Pharmaceuticals Inc, United States Army Office Surgeon General, Solvay Pharmaceuticals
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1317 | |||
| PharmGKB | PA451185 | |||
| Human Metabolome Database | HMDB0014685 | |||
| DrugBank | DB00545 | |||
| PubChem: Thomson Pharma | 15171335 | |||
| PubChem | 4991 | |||
| Mcule | MCULE-2045762718 | |||
| LINCS | LSM-5770 | |||
| Nikkaji | J10.938J | |||
| BindingDB | 50313079 | |||
| EPA CompTox Dashboard | DTXSID20165786 | |||
| DrugCentral | 2330 | |||
| Brenda | 6250 | |||
| ChemicalBook | CB91442611 | |||
| Guide to Pharmacology | 8994 | |||
| rxnorm | REGONOL | MESTINON | PYRIDOSTIGMINE | PYRIDOSTIGMINE BROMIDE |
| KEGG Ligand | C07410 | |||
| ChEBI | 8665 | |||
| ZINC | ZINC000000002009 |
